A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Conditions:   Cancer;   Melanoma Stage III;   Melanoma Stage IV;   Cutaneous Melanoma;   Osteosarcoma;   Carcinoma, Squamous Cell;   Carcinoma, Basal Cell Intervention:   Biological: KB707 Sponsor:   Krystal Biotech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials

To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Condition:   Ewing Sarcoma Intervention:   Drug: Naxitamab Sponsors:   Anna Raciborska;   Wroclaw Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Conditions:   Cancer;   Melanoma Stage III;   Melanoma Stage IV;   Cutaneous Melanoma;   Osteosarcoma;   Carcinoma, Squamous Cell;   Carcinoma, Basal Cell Intervention:   Biological: KB707 Sponsor:   Krystal Biotech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials

To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Condition:   Ewing Sarcoma Intervention:   Drug: Naxitamab Sponsors:   Anna Raciborska;   Wroclaw Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials